These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1002 related articles for article (PubMed ID: 11872675)
1. Increased insulin sensitivity in IGF-I receptor--deficient brown adipocytes. Mur C; Valverde AM; Kahn CR; Benito M Diabetes; 2002 Mar; 51(3):743-54. PubMed ID: 11872675 [TBL] [Abstract][Full Text] [Related]
2. Essential role of insulin-like growth factor I receptor in insulin-induced fetal brown adipocyte differentiation. Mur C; Arribas M; Benito M; Valverde AM Endocrinology; 2003 Feb; 144(2):581-93. PubMed ID: 12538620 [TBL] [Abstract][Full Text] [Related]
3. Association of insulin receptor substrate 1 (IRS-1) y895 with Grb-2 mediates the insulin signaling involved in IRS-1-deficient brown adipocyte mitogenesis. Valverde AM; Mur C; Pons S; Alvarez AM; White MF; Kahn CR; Benito M Mol Cell Biol; 2001 Apr; 21(7):2269-80. PubMed ID: 11259577 [TBL] [Abstract][Full Text] [Related]
4. Insulin receptor substrate (IRS) proteins IRS-1 and IRS-2 differential signaling in the insulin/insulin-like growth factor-I pathways in fetal brown adipocytes. Valverde AM; Lorenzo M; Pons S; White MF; Benito M Mol Endocrinol; 1998 May; 12(5):688-97. PubMed ID: 9605931 [TBL] [Abstract][Full Text] [Related]
5. Insulin signaling leading to proliferation, survival, and membrane ruffling in C2C12 myoblasts. Conejo R; Lorenzo M J Cell Physiol; 2001 Apr; 187(1):96-108. PubMed ID: 11241354 [TBL] [Abstract][Full Text] [Related]
6. Tyrosine phosphorylation-dependent and -independent role of Shc in the regulation of IGF-1-induced mitogenesis and glycogen synthesis. Sasaoka T; Ishiki M; Wada T; Hori H; Hirai H; Haruta T; Ishihara H; Kobayashi M Endocrinology; 2001 Dec; 142(12):5226-35. PubMed ID: 11713219 [TBL] [Abstract][Full Text] [Related]
7. Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells. Guvakova MA; Surmacz E Cancer Res; 1997 Jul; 57(13):2606-10. PubMed ID: 9205064 [TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor I synergizes with interleukin 4 for hematopoietic cell proliferation independent of insulin receptor substrate expression. Soon L; Flechner L; Gutkind JS; Wang LH; Baserga R; Pierce JH; Li W Mol Cell Biol; 1999 May; 19(5):3816-28. PubMed ID: 10207105 [TBL] [Abstract][Full Text] [Related]
9. Differential regulation of insulin receptor substrate-2 and mitogen-activated protein kinase tyrosine phosphorylation by phosphatidylinositol 3-kinase inhibitors in SH-SY5Y human neuroblastoma cells. Kim B; Leventhal PS; White MF; Feldman EL Endocrinology; 1998 Dec; 139(12):4881-9. PubMed ID: 9832424 [TBL] [Abstract][Full Text] [Related]
10. p42/p44 mitogen-activated protein kinases activation is required for the insulin-like growth factor-I/insulin induced proliferation, but inhibits differentiation, in rat fetal brown adipocytes. Porras A; Alvarez AM; Valladares A; Benito M Mol Endocrinol; 1998 Jun; 12(6):825-34. PubMed ID: 9626658 [TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor-I-dependent signal transduction pathways leading to the induction of cell growth and differentiation of human neuroblastoma cell line SH-SY5Y: the roles of MAP kinase pathway and PI 3-kinase pathway. Kurihara S; Hakuno F; Takahashi S Endocr J; 2000 Dec; 47(6):739-51. PubMed ID: 11228049 [TBL] [Abstract][Full Text] [Related]
12. Stimulation of pancreatic beta-cell proliferation by growth hormone is glucose-dependent: signal transduction via janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) with no crosstalk to insulin receptor substrate-mediated mitogenic signalling. Cousin SP; Hügl SR; Myers MG; White MF; Reifel-Miller A; Rhodes CJ Biochem J; 1999 Dec; 344 Pt 3(Pt 3):649-58. PubMed ID: 10585851 [TBL] [Abstract][Full Text] [Related]
13. PTEN inhibits insulin-stimulated MEK/MAPK activation and cell growth by blocking IRS-1 phosphorylation and IRS-1/Grb-2/Sos complex formation in a breast cancer model. Weng LP; Smith WM; Brown JL; Eng C Hum Mol Genet; 2001 Mar; 10(6):605-16. PubMed ID: 11230180 [TBL] [Abstract][Full Text] [Related]
14. Roles of insulin receptor substrate-1 and Shc on insulin-like growth factor I receptor signaling in early passages of cultured human fibroblasts. Takahashi Y; Tobe K; Kadowaki H; Katsumata D; Fukushima Y; Yazaki Y; Akanuma Y; Kadowaki T Endocrinology; 1997 Feb; 138(2):741-50. PubMed ID: 9003010 [TBL] [Abstract][Full Text] [Related]
15. Role of IRS-3 in the insulin signaling of IRS-1-deficient brown adipocytes. Arribas M; Valverde AM; Benito M J Biol Chem; 2003 Nov; 278(46):45189-99. PubMed ID: 12944402 [TBL] [Abstract][Full Text] [Related]
16. The critical role of Shc in insulin-like growth factor-I-mediated mitogenesis and differentiation in 3T3-L1 preadipocytes. Boney CM; Gruppuso PA; Faris RA; Frackelton AR Mol Endocrinol; 2000 Jun; 14(6):805-13. PubMed ID: 10847583 [TBL] [Abstract][Full Text] [Related]
17. Insulin receptor substrate 2 and Shc play different roles in insulin-like growth factor I signaling. Kim B; Cheng HL; Margolis B; Feldman EL J Biol Chem; 1998 Dec; 273(51):34543-50. PubMed ID: 9852124 [TBL] [Abstract][Full Text] [Related]
18. The effect of cyclic adenosine monophosphate on the mitogen-activated protein kinase pathway depends on both the cell type and the type of tyrosine kinase-receptor. Calleja V; Ruiz Enríquez P; Filloux C; Peraldi P; Baron V; Van Obberghen E Endocrinology; 1997 Mar; 138(3):1111-20. PubMed ID: 9048617 [TBL] [Abstract][Full Text] [Related]
19. Insulin signaling in insulin receptor substrate (IRS)-1-deficient brown adipocytes: requirement of IRS-1 for lipid synthesis. Valverde AM; Kahn CR; Benito M Diabetes; 1999 Nov; 48(11):2122-31. PubMed ID: 10535444 [TBL] [Abstract][Full Text] [Related]